DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2  (02-2018)

Period of time： 2018年2期

Publisher： John Wiley & Sons Inc

Founded in： 1999

Total resources： 46

E-ISSN： 1463-1326|20|2

ISSN： 1462-8902

Subject： R Medicine and Health

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2

Menu

Cover Image, Volume 20, Issue 2

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2 , Vol. 20, Iss. 2, 2018-02 , pp. i-i

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Diabetes, Obesity and Metabolism

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2 , Vol. 20, Iss. 2, 2018-02 , pp. 231-232

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors)

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2 , Vol. 20, Iss. 2, 2018-02 , pp. 233-237

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose‐lowering interventions

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2 , Vol. 20, Iss. 2, 2018-02 , pp. 238-244

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

The challenges of achieving postprandial glucose control using closed‐loop systems in patients with type 1 diabetes

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2 , Vol. 20, Iss. 2, 2018-02 , pp. 245-256

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Therapeutic application of GPR119 ligands in metabolic disorders

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2 , Vol. 20, Iss. 2, 2018-02 , pp. 257-269

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2 , Vol. 20, Iss. 2, 2018-02 , pp. 270-282

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

A first‐in‐human pharmacodynamic and pharmacokinetic study of a fully human anti‐glucagon receptor monoclonal antibody in normal healthy volunteers

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2 , Vol. 20, Iss. 2, 2018-02 , pp. 283-291

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40‐week extension of the GUARD randomized study

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2 , Vol. 20, Iss. 2, 2018-02 , pp. 292-300

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 20,issue 2 , Vol. 20, Iss. 2, 2018-02 , pp. 301-308

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Previous 1 2 3 4 Next Display item(s) per page Total 32 item(s)